ALPHAMAB-B (09966) announced that it spent HK$1.8499 million to buy back 220,000 shares on September 8, 2026.
The repurchase reflects the company's ongoing commitment to enhancing shareholder value through strategic capital management initiatives.
ALPHAMAB-B (09966) announced that it spent HK$1.8499 million to buy back 220,000 shares on September 8, 2026.
The repurchase reflects the company's ongoing commitment to enhancing shareholder value through strategic capital management initiatives.
Comments